Skip to main
SNWV
SNWV logo

SNWV Stock Forecast & Price Target

SNWV Analyst Ratings

Based on 2 analyst ratings
Buy
Strong Buy 50%
Buy 50%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

SANUWAVE Health Inc. reported a substantial revenue growth of 60% year-over-year, reaching $32.6 million, primarily driven by increased sales of its systems and consumables. The company also achieved a significant improvement in Adjusted EBITDA, increasing by 28 percentage points to 22%, reflecting strong operational efficiency despite a modest rise in operating expenses to $6.4 million. This combination of robust sales growth and enhanced profitability metrics positions SANUWAVE favorably within the regenerative medicine market.

Bears say

The first quarter applicator usage for SANUWAVE Health was modestly down compared to the previous quarter, primarily attributed to the typical seasonal behavior of patients delaying treatments due to resetting insurance deductibles. Additionally, the company faces fundamental challenges including margin compression, competitive pressures, reduced productivity among sales representatives, and potential manufacturing setbacks, all of which could adversely affect financial performance. These factors collectively contribute to a negative outlook on SANUWAVE Health's stock, as they suggest ongoing operational and market vulnerabilities.

SNWV has been analyzed by 2 analysts, with a consensus rating of Buy. 50% of analysts recommend a Strong Buy, 50% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of SANUWAVE Health Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About SANUWAVE Health Inc (SNWV) Forecast

Analysts have given SNWV a Buy based on their latest research and market trends.

According to 2 analysts, SNWV has a Buy consensus rating as of Oct 29, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $55, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $55, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

SANUWAVE Health Inc (SNWV)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.